The New U.s. Medical Reform Drug Prices Moved Down The Risk Of Investors Cheese? - U.s. Medical

U.S. medical reform the wheel could start, the United States President Barack Obama's commitment of government within the next ten years invested 630 billion U.S. dollars medical reform. Expand Health Insurance Coverage

, reducing overall drug prices??? New medical reform policy, not only will really change the United States Medicine Market structure, and associated insurance, bio-manufacturing, high-tech industries have a profound impact. Medical issues surrounding the price cut, has shared the feast of the U.S. high-tech capital return on the risk of investors, without regard to R & D and venture capital investment costs and risks borne by, or short-term cost savings will be at the expense of innovation and vitality of the industry.

American Medical inefficient Efficiency is too low, the United States The new medical reform The main reason for a fight. "The United States long-term health care costs the world's highest annual expenditure of more than 2 trillion U.S. dollars. Even by the standards of developed countries, the U.S. health care spending is too much. Compared with other developed countries, the U.S. health care health care systems rely mainly on market allocation of medical resources. for medical products and services, pricing, health insurance coverage and other issues less government intervention.

Actual operation of such a system, the effect is the high cost and low efficiency. "Monita (Beijing) Investment Development Corporation analyst Sha said this. According to statistics Monita, 2007, health costs accounted for the developed countries the proportion of GDP statistics, the United States accounted for 16%, UK 8.4%, and France accounted for 11 %, Germany 10.4%. In addition, developed countries in public expenditure in 2007 accounted for the proportion of health costs, the U.S. level was 45%, Britain 82% France 79%, Germany 77%. However, in the Economic Cooperation OECD countries, the United States health of the population in the poor level. So many indicators from the U.S. health care system compared with other developed countries is inefficient.

"U.S. drug prices than other developed countries, 50% higher than similar products, even assuming the Pharmacy Industry's global R & D costs must be borne by the United States, the United States Drugs Prices remain very high premium. "Zhejiang Securities analyst Kevin pointed out that Jiang Yan, one of the core U.S. medical reform is to lower health care costs, which is an important drug prices.

Tax cut prices to combat medical innovation?

Drug prices, touched a sensitive nerve in the risk of investors. U.S. venture capitalists JackLasersohn the past 30 years has been investment in health industries, mainly SMEs, to provide initial start-up capital. Recently, he received "The Wall Street Journal" interview, medical reform has just passed a new bill on the impact of innovation and industry, he is not optimistic. "The new legislation includes a collection of medical equipment Sell Tax, on the lack of funds or tax money for innovative companies is a terrible idea. "Lasersohn said in R & D stage companies, funding sources and fund-raising only hope is that this is the only discretionary money, need to spend wisely, rather than taxes on. He believes that venture capital industry, this will be very disappointed.

As medical reform bill also created a separate payment of the Advisory Committee on how to slow the growth of medical costs and improve quality of medical service to provide advice to Congress, which Lasersohn worried about innovation again be affected. "Innovative, if not properly protected and fulfilled, will be against the bill targets the most vulnerable, yet sophisticated technology and equipment items could not even start, because it is difficult to be supported. While medical and health services is the most important factor innovative approaches and systems. "

And Lasersohn have the same negative attitude of some medical reform bill by the exact impact of pharmaceutical companies. In addition, insurance companies, health insurance in the past, a substantial benefit from the phenomenon will disappear, because the new law regulating the insurance industry may not refuse to cover, even if the insured person is currently suffering from the disease, but also on the bill the insurance company to make the maximum profit level strict limits, is thus clear that the valuation of the insurance sector will therefore be seriously adversely affected.

by: gaga

POST COMMENT

The New Medical Reform Will Allow Pharmaceutical Market Face A Reshuffle - Health Care Reform, The New Frontier - 2010 In Review The Output Value Of China Instrument Through The Perspective Of The Development Of New Industry The Demand Value of China Bearing Industry Will Reach A New Height Again in 2011 Some Things To Consider When Buying A New Home Knox Division New Water Heater Dst-f-670 Hot Market - Water Heater, Knox Secretary Dst-f-670-hc Garden Lighting Outlet Is Your One-stop Garden Lighting Shop Solar Powered Garden Lights Outlet Different Ideas For Secure New Jersey Dating RobinGupta.com - All New Look With Web Designing Services Make Your Garden Dazzle With Garden Lighting Dell Laptop Uses A New Cooling Technology With Intel Present New Year Plan In Powerpoint File On Tv With Powerpoint To Dvd Converter